IGC Pharma (NYSE: IGC) CEO Discusses AI, Alzheimer’s Drug Development and Key 2026 Catalysts on The Street Podcast
Investors following the rapidly growing Alzheimer’s disease, Artificial Intelligence (AI), and biotechnology sectors now have an opportunity to hear directly from IGC Pharma, Inc. (NYSE American: IGC) CEO Ram Mukunda…
